Skip to main navigation Skip to search Skip to main content

Evolution of joint health and physical activity in people with haemophilia A without factor VIII inhibitors switching to emicizumab prophylaxis: 12-month interim analysis of the BEYOND ABR study

  • R Kruse-Jarres
  • , G Castaman
  • , MN D Di Minno
  • , D Stephensen
  • , S Lobet
  • , S Barlera
  • , C Brocchieri
  • , V Jiménez-Yuste
  • , J Oldenburg
  • Washington Center for Bleeding Disorders
  • Careggi University Hospital
  • University of Naples Federico II
  • Haemostasis and Thrombosis Unit
  • PAREXEL International
  • F. Hoffmann-La Roche Ltd
  • Autónoma University
  • University Hospital Bonn

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S36-S36
JournalHamostaseologie
Volume46
Issue numberS 01
DOIs
Publication statusPublished - 17 Feb 2026

Keywords

  • Joint health
  • Physical activity
  • Haemophilia A
  • Emicizumab

Cite this